Academic development of advanced therapies-How to foster their future in the clinic
- PMID: 39980090
- DOI: 10.1002/bcp.70024
Academic development of advanced therapies-How to foster their future in the clinic
References
REFERENCES
-
- REGULATION (EC) no 1394/2007 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 13 November 2007 on advanced therapy medicinal products and amending directive 2001/83/EC and regulation (EC) no 726/2004, 1394/2007; 2007.
-
- U.S. Food and Drug Administration. Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies; 2019. Available from: https://www.fda.gov/news-events/press-announcements/statement-fda-commis...
-
- Hubert A. Advanced therapies sector overview ‐ gene therapy for rare disorders Europe 2019; 2019. Available from: https://alliancerm.org/wp-content/uploads/2019/10/GT-for-Rare-Disorders-...
-
- European Medicines Agency. Cat quarterly highlights and approved ATMPs; 2024. Available from: https://www.ema.europa.eu/en/documents/committee-report/cat-quarterly-hi...
-
- U.S. Food and Drug Administration. Approved cellular and gene therapy products; 2024. [cited 2024 31/08/2024]. Available from: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-produ...
Publication types
LinkOut - more resources
Full Text Sources
